{"id":51179,"date":"2026-06-26T11:29:09","date_gmt":"2026-06-26T09:29:09","guid":{"rendered":"https:\/\/semaxpolska.com\/?p=51179"},"modified":"2026-06-21T09:33:51","modified_gmt":"2026-06-21T07:33:51","slug":"pinealon-si-alte-peptide-comparatie-cu-epitalon-semax-cerebrolysin-ss-31-si-tesamorelin","status":"publish","type":"post","link":"https:\/\/bioevidencehub.com\/ro\/pinealon-a-inne-peptydy-porownanie-z-epitalon-semax-cerebrolysin-ss-31-i-tesamorelin\/","title":{"rendered":"Pinealon \u0219i alte peptide: compara\u021bie cu Epitalon, Semax, Cerebrolysin, SS-31 \u0219i Tesamorelin"},"content":{"rendered":"<p>&nbsp;<\/p>\n<h2>Pinealon \u0219i alte peptide<\/h2>\n<p>Odat\u0103 cu cre\u0219terea interesului pentru interven\u021biile bazate pe peptide, Pinealon este adesea comparat cu c\u00e2teva peptide binecunoscute, printre care Epitalon, Semax, Cerebrolysin, SS-31 \u0219i Tesamorelin. De\u0219i aceste compu\u0219i sunt adesea discuta\u021bi \u00een acelea\u0219i contexte, ei difer\u0103 semnificativ \u00een ceea ce prive\u0219te structura molecular\u0103, \u021bintele biologice, mecanismele de ac\u021biune propuse \u0219i domeniile de cercetare \u0219tiin\u021bific\u0103.<\/p>\n<h3>Pinealon vs Epitalon<\/h3>\n<p>Pinealonul \u0219i Epitalonul sunt peptide bioregulatoare dezvoltate de Vladimir Khavinson \u0219i colaboratorii s\u0103i. Ambele sunt adesea men\u021bionate \u00een contextul \u00eemb\u0103tr\u00e2nirii s\u0103n\u0103toase \u0219i al cercet\u0103rilor privind longevitatea. \u00cen ciuda acestor asem\u0103n\u0103ri, ele sunt totu\u0219i molecule diferite. Pinealonul este un tripeptid format din acid glutamic, acid asparaginic \u0219i arginin\u0103 (Glu-Asp-Arg; EDR), \u00een timp ce Epitalon este un tetrapeptid format din alanin\u0103, acid glutamic, acid asparaginic \u0219i glicin\u0103 (Ala-Glu-Asp-Gly) (1,2).<\/p>\n<p>Cercet\u0103rile privind Pinealon s-au concentrat \u00een principal pe neuroprotec\u021bie, func\u021biile cognitive, reglarea stresului oxidativ, supravie\u021buirea neuronilor \u0219i modific\u0103rile neurologice legate de v\u00e2rst\u0103 (3\u20138). Studiile experimentale au demonstrat c\u0103 Pinealon reduce nivelul formelor reactive de oxigen (ROS), \u00eembun\u0103t\u0103\u021be\u0219te viabilitatea neuronilor, cre\u0219te expresia serotoninei \u0219i protejeaz\u0103 celulele nervoase \u00eempotriva diverselor forme de stres celular (4\u20138).<\/p>\n<p>La r\u00e2ndul lor, studiile privind Epitalon se concentreaz\u0103 \u00een principal pe biologia \u00eemb\u0103tr\u00e2nirii, activitatea telomerazei, reglarea melatoninei, func\u021bionarea ritmului circadian \u0219i mecanismele legate de longevitate. De\u0219i ambele peptide sunt clasificate drept bioregulatori geroprotectori, Pinealon este de obicei perceput ca un peptid cu o ac\u021biune mai neurocentric\u0103, \u00een timp ce Epitalon este asociat mai des cu studiile anti-\u00eemb\u0103tr\u00e2nire la nivel sistemic \u0219i cu func\u021bionarea glandei pineale.<\/p>\n<p>Deoarece ambele peptide pot ac\u021biona asupra unor c\u0103i biologice diferite, unii cercet\u0103tori \u0219i utilizatori ai peptidelor consider\u0103 c\u0103 Pinealon \u0219i Epitalon sunt compu\u0219i poten\u021bial complementari. Cu toate acestea, studiile clinice controlate care evalueaz\u0103 utilizarea lor concomitent\u0103 sunt foarte limitate \u0219i, p\u00e2n\u0103 \u00een prezent, nu s-au efectuat studii ample pe oameni care s\u0103 confirme siguran\u021ba sau eficacitatea unei astfel de abord\u0103ri.<\/p>\n<h3>Pinealon vs Semax<\/h3>\n<p>Pinealonul \u0219i Semaxul sunt adesea comparate, deoarece ambele au fost studiate din perspectiva neuroprotec\u021biei \u0219i a sus\u021binerii func\u021biilor cognitive. Cu toate acestea, ele apar\u021bin unor familii de peptide complet diferite.<\/p>\n<p>Pinealonul este un tripeptid bioregulator scurt (Glu-Asp-Arg), \u00een timp ce Semax este un analog sintetic al hormonului adrenocorticotrop ACTH (4-10), dezvoltat \u00een Rusia pentru aplica\u021bii neurologice (9,10).<\/p>\n<p>Datele disponibile sugereaz\u0103 c\u0103 Pinealon \u00ee\u0219i exercit\u0103 multe dintre efectele sale biologice prin reglarea stresului oxidativ, mecanisme epigenetice, modularea expresiei genelor, influen\u021barea c\u0103ilor legate de serotonin\u0103 \u0219i sus\u021binerea supravie\u021buirii neuronilor (4\u20138). Pe de alt\u0103 parte, studiile privind Semax s-au concentrat \u00een principal asupra activit\u0103\u021bii neurotrofice, modul\u0103rii sistemelor neurotransmi\u021b\u0103toare, neuroprotec\u021biei \u00een urma leziunilor ischemice \u0219i \u00eembun\u0103t\u0103\u021birii func\u021biilor cognitive (9,10).<\/p>\n<p>De\u0219i ambele peptide sunt studiate din perspectiva s\u0103n\u0103t\u0103\u021bii creierului \u0219i a func\u021biilor cognitive, studiile privind Semax subliniaz\u0103 \u00een primul r\u00e2nd efectele neurotrofice \u0219i cele legate de neurotransmi\u021b\u0103tori, \u00een timp ce studiile privind Pinealon se concentreaz\u0103 mai mult pe protec\u021bia celular\u0103, biologia \u00eemb\u0103tr\u00e2nirii, reducerea stresului oxidativ \u0219i reglarea epigenetic\u0103.<\/p>\n<p>P\u00e2n\u0103 \u00een prezent, nu s-au efectuat studii clinice directe care s\u0103 compare Pinealon \u0219i Semax la oameni.<\/p>\n<h3>Pinealon vs Cerebrolysin<\/h3>\n<p>Cerebrolysin difer\u0103 semnificativ de Pinealon at\u00e2t din punct de vedere al compozi\u021biei, c\u00e2t \u0219i al complexit\u0103\u021bii. Pinealon este format dintr-un singur tripeptid sintetic, \u00een timp ce Cerebrolysin este un amestec complex de neuropeptide cu greutate molecular\u0103 mic\u0103 \u0219i fragmente de aminoacizi ob\u021binute din \u021besutul cerebral al porcilor.<\/p>\n<p>Cercet\u0103rile privind Cerebrolysin s-au concentrat \u00een principal pe recuperarea dup\u0103 accident vascular cerebral, leziuni cerebrale traumatice, demen\u021ba vascular\u0103 \u0219i boala Alzheimer. \u00cen schimb, studiile privind Pinealon s-au axat \u00een primul r\u00e2nd pe protec\u021bia neuronilor, rezisten\u021ba la stresul oxidativ, func\u021biile cognitive \u0219i \u00eemb\u0103tr\u00e2nirea s\u0103n\u0103toas\u0103 (3\u20138).<\/p>\n<p>O diferen\u021b\u0103 semnificativ\u0103 \u00eentre aceste substan\u021be o reprezint\u0103 amploarea datelor clinice disponibile. Cerebrolysin a fost evaluat \u00een cadrul unor programe de studii clinice mult mai ample dec\u00e2t Pinealon. Datele referitoare la Pinealon sunt \u00eenc\u0103 limitate \u0219i provin \u00een principal din studii preclinice \u0219i din studii clinice de amploare relativ redus\u0103.<\/p>\n<p>De\u0219i ambele compu\u0219i sunt studia\u021bi din perspectiva propriet\u0103\u021bilor lor neuroprotectoare, ace\u0219tia ac\u021bioneaz\u0103 prin mecanisme biologice diferite \u0219i nu ar trebui considera\u021bi interschimbabili.<\/p>\n<h3>Pinealon vs SS-31<\/h3>\n<p>SS-31 (elamipretid\u0103) este un peptid cu \u021bint\u0103 mitocondrial\u0103, conceput pentru a proteja func\u021biile mitocondriale \u0219i a reduce leziunile oxidative la nivel celular. Spre deosebire de Pinealon, care pare s\u0103 influen\u021beze expresia genelor, supravie\u021buirea neuronilor, sinteza serotoninei \u0219i c\u0103ile de semnalizare celular\u0103, SS-31 ac\u021bioneaz\u0103 \u00een principal asupra membranelor mitocondriale \u0219i asupra bioenergeticii celulare.<\/p>\n<p>Ambele peptide au fost studiate din punctul de vedere al capacit\u0103\u021bii lor de a reduce stresul oxidativ. S-a demonstrat c\u0103 Pinealon limiteaz\u0103 acumularea formelor reactive de oxigen \u0219i reduce leziunile celulare \u00een condi\u021bii de stres oxidativ (4,5), \u00een timp ce studiile privind SS-31 s-au concentrat pe \u00eembun\u0103t\u0103\u021birea performan\u021bei mitocondriilor \u0219i pe limitarea leziunilor rezultate din disfunc\u021bionalitatea acestora.<\/p>\n<p>P\u00e2n\u0103 \u00een prezent, nu s-au efectuat studii directe care s\u0103 compare Pinealon cu SS-31.<\/p>\n<h3>Pinealon vs Tesamorelin<\/h3>\n<p>Pinealonul \u0219i tesamorelinul apar\u021bin unor categorii de peptide complet diferite \u0219i au fost studiate \u00een vederea unor obiective biologice cu totul diferite.<\/p>\n<p>Pinealonul este un tripeptid neuroregulator \u0219i bioregulator, studiat \u00een principal \u00een contextul neuroprotec\u021biei, al func\u021biilor cognitive, al regl\u0103rii stresului oxidativ \u0219i al \u00eemb\u0103tr\u00e2nirii s\u0103n\u0103toase (3\u20138). Tesamorelin, pe de alt\u0103 parte, este un analog al hormonului de eliberare a hormonului de cre\u0219tere (GHRH), care stimuleaz\u0103 secre\u021bia hormonului de cre\u0219tere endogen \u0219i cre\u0219te produc\u021bia factorului de cre\u0219tere insulinopodob 1 (IGF-1).<\/p>\n<p>Cercet\u0103rile privind Tesamorelin s-au concentrat \u00een principal pe reducerea \u021besutului adipos visceral, compozi\u021bia corporal\u0103, s\u0103n\u0103tatea metabolic\u0103 \u0219i fiziologia legat\u0103 de hormonul de cre\u0219tere. Pe de alt\u0103 parte, studiile privind Pinealon s-au concentrat pe protec\u021bia neuronilor, procesele de \u00eenv\u0103\u021bare \u0219i memorie, expresia serotoninei \u0219i mecanismele celulare asociate \u00eemb\u0103tr\u00e2nirii.<\/p>\n<p>Av\u00e2nd \u00een vedere aceste diferen\u021be semnificative din punct de vedere mecanic, \u00eentrebarea \u201eTesamorelin sau Pinealon?\u201d nu reprezint\u0103 o compara\u021bie direct\u0103. Ambele peptide sunt studiate \u00een scopuri \u0219tiin\u021bifice diferite \u0219i ac\u021bioneaz\u0103 asupra unor sisteme fiziologice distincte.<\/p>\n<h2>Perspectiva \u0219tiin\u021bific\u0103 general\u0103<\/h2>\n<p>Pinealon se distinge dintre numeroasele peptide despre care se vorbe\u0219te adesea prin combina\u021bia de propriet\u0103\u021bi neuroprotectoare, antioxidante, epigenetice \u0219i geroprotectoare. Datele actuale sugereaz\u0103 c\u0103 Pinealon poate sus\u021bine supravie\u021buirea neuronilor, reduce stresul oxidativ, influen\u021ba c\u0103ile legate de serotonin\u0103 \u0219i regla func\u021biile celulare asociate cu \u00eemb\u0103tr\u00e2nirea \u0219i neuroprotec\u021bia.<\/p>\n<p>Cu toate acestea, studiile clinice directe care compar\u0103 Pinealon cu alte peptide r\u0103m\u00e2n foarte limitate. Prin urmare, \u00een prezent nu se pot trage concluzii clare cu privire la eficacitatea relativ\u0103, siguran\u021ba sau avantajul fiec\u0103rui compus \u00een parte. Sunt necesare studii suplimentare, bine concepute, efectuate pe oameni, pentru a caracteriza mai bine asem\u0103n\u0103rile \u0219i diferen\u021bele dintre aceste peptide.<\/p>\n<h3>Men\u021biune<\/h3>\n<p>Con\u021binutul are caracter exclusiv educativ \u0219i informativ \u0219i nu trebuie interpretat ca sfat medical, diagnostic, tratament sau recomandare profesional\u0103. Pinealon, Epitalon, Semax, Cerebrolysin, SS-31 \u0219i Tesamorelin difer\u0103 semnificativ \u00een ceea ce prive\u0219te structura, mecanismele de ac\u021biune \u0219i domeniile de cercetare \u0219tiin\u021bific\u0103. Pinealon nu a fost aprobat de Agen\u021bia American\u0103 pentru Alimente \u0219i Medicamente (FDA), de Agen\u021bia European\u0103 pentru Medicamente (EMA) \u0219i nici de majoritatea celorlalte autorit\u0103\u021bi de reglementare pentru tratamentul tulbur\u0103rilor neurologice, al tulbur\u0103rilor cognitive, al afec\u021biunilor legate de \u00eemb\u0103tr\u00e2nire sau al oric\u0103ror alte indica\u021bii medicale. O mare parte din datele disponibile provine din studii preclinice \u0219i din studii limitate efectuate pe oameni. Sunt necesare studii clinice suplimentare, bine concepute, pentru a determina mai bine eficacitatea, siguran\u021ba \u0219i efectele pe termen lung ale acestor peptide \u0219i pentru a stabili dac\u0103 exist\u0103 diferen\u021be semnificative \u00eentre ele \u00een condi\u021bii clinice.<\/p>\n<h4>Referin\u021be<\/h4>\n<ol>\n<li data-start=\"16\" data-end=\"126\"><span style=\"font-size: 10pt;\">Date privind compozi\u021bia \u0219i propriet\u0103\u021bile chimice ale Pinealonului (peptida EDR).<\/span><br data-start=\"74\" data-end=\"77\" \/><span style=\"font-size: 10pt;\">Wikipedia: <a class=\"decorated-link\" href=\"https:\/\/en.wikipedia.org\/wiki\/Pinealon?utm_source=chatgpt.com\" target=\"_new\" rel=\"noopener\" data-start=\"88\" data-end=\"126\">https:\/\/en.wikipedia.org\/wiki\/Pinealon<\/a><\/span><\/li>\n<li data-start=\"128\" data-end=\"546\"><span style=\"font-size: 10pt;\">Fedoreyeva, L. I., Kireev, I. I., Khavinson, V. K. \u0219i Vanyushin, B. F. (2011). <em data-start=\"211\" data-end=\"383\">P\u0103trunderea peptidelor scurte marcate cu fluor \u00een nucleul celulelor HeLa \u0219i interac\u021biunea specific\u0103 in vitro a peptidelor cu oligonucleotidele dezoxiribonucleice \u0219i ADN-ul<\/em>. <em data-start=\"385\" data-end=\"412\">Biochimie (Moscova), 76<\/em>(11), 1210\u20131219. <a class=\"decorated-link cursor-pointer\" target=\"_new\" rel=\"noopener\" data-start=\"429\" data-end=\"470\">https:\/\/doi.org\/10.1134\/S0006297911110022<\/a><\/span><br data-start=\"470\" data-end=\"473\" \/><span style=\"font-size: 10pt;\">Link c\u0103tre jurnal: <a class=\"decorated-link\" href=\"https:\/\/link.springer.com\/article\/10.1134\/S0006297911110022?utm_source=chatgpt.com\" target=\"_new\" rel=\"noopener\" data-start=\"487\" data-end=\"546\">https:\/\/link.springer.com\/article\/10.1134\/S0006297911110022<\/a><\/span><\/li>\n<li data-start=\"548\" data-end=\"892\"><span style=\"font-size: 10pt;\">Meshchaninov, V. N., Tkachenko, E. L., Zharkov, S. V., Gavrilov, I. V. \u0219i Katyreva, Y. E. (2015). <em data-start=\"650\" data-end=\"798\">Efectul peptidelor sintetice asupra \u00eemb\u0103tr\u00e2nirii la pacien\u021bii cu polimorbiditate cronic\u0103 \u0219i sindrom cerebral organic al sistemului nervos central \u00een remisie<\/em>. <em data-start=\"800\" data-end=\"829\">Progrese \u00een gerontologie, 28<\/em>(1), 62\u201367.<\/span><br data-start=\"840\" data-end=\"843\" \/><span style=\"font-size: 10pt;\">PubMed: <a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26390612\/\" target=\"_new\" rel=\"noopener\" data-start=\"851\" data-end=\"892\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26390612\/<\/a><\/span><\/li>\n<li data-start=\"894\" data-end=\"1209\"><span style=\"font-size: 10pt;\">Khavinson, V., Ribakova, Y., \u0219i colab. (2011). <em data-start=\"942\" data-end=\"1054\">Pinealonul cre\u0219te viabilitatea celular\u0103 prin reducerea nivelului radicalilor liberi \u0219i activarea proceselor de proliferare<\/em>. <em data-start=\"1056\" data-end=\"1083\">Rejuvenation Research, 14<\/em>(5), 517\u2013523. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.1089\/rej.2011.1172\" target=\"_new\" rel=\"noopener\" data-start=\"1097\" data-end=\"1134\">https:\/\/doi.org\/10.1089\/rej.2011.1172<\/a><\/span><br data-start=\"1134\" data-end=\"1137\" \/><span style=\"font-size: 10pt;\">Link c\u0103tre jurnal: <a class=\"decorated-link\" href=\"https:\/\/journals.sagepub.com\/doi\/abs\/10.1089\/rej.2011.1172\" target=\"_new\" rel=\"noopener\" data-start=\"1151\" data-end=\"1209\">https:\/\/journals.sagepub.com\/doi\/abs\/10.1089\/rej.2011.1172<\/a><\/span><\/li>\n<li data-start=\"1211\" data-end=\"1608\"><span style=\"font-size: 10pt;\">Arutjunyan, A. V., Kozina, L. S., Stvolinsky, S. L., Bulygina, E. R., Mashkina, A. P. \u0219i Khavinson, V. K. (2012). <em data-start=\"1329\" data-end=\"1401\">Pinealon protejeaz\u0103 puii de \u0219obolan \u00eempotriva hiperhomocisteinemiei prenatale<\/em>. <em data-start=\"1403\" data-end=\"1444\">Revista interna\u021bional\u0103 de peptide, 2012<\/em>, 109757. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.1155\/2012\/109757\" target=\"_new\" rel=\"noopener\" data-start=\"1454\" data-end=\"1489\">https:\/\/doi.org\/10.1155\/2012\/109757<\/a><\/span><br data-start=\"1489\" data-end=\"1492\" \/><span style=\"font-size: 10pt;\">PubMed: <a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22567179\/\" target=\"_new\" rel=\"noopener\" data-start=\"1500\" data-end=\"1541\">https:\/\/pubmed.ncbi.nlm.nih.gov\/22567179\/<\/a><\/span><br data-start=\"1541\" data-end=\"1544\" \/><span style=\"font-size: 10pt;\">Text integral PMC: <a class=\"decorated-link\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3342713\/?utm_source=chatgpt.com\" target=\"_new\" rel=\"noopener\" data-start=\"1559\" data-end=\"1608\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3342713\/<\/a><\/span><\/li>\n<li data-start=\"1610\" data-end=\"1957\"><span style=\"font-size: 10pt;\">Khavinson, V. K., Lin\u2019kova, N. S., Tarnovskaya, S. I., Umnov, R. S., Elashkina, E. V. \u0219i Durnova, A. O. (2014). <em data-start=\"1726\" data-end=\"1798\">Peptidele scurte stimuleaz\u0103 expresia serotoninei \u00een celulele cortexului cerebral<\/em>. <em data-start=\"1800\" data-end=\"1852\">Buletinul de Biologie Experimental\u0103 \u0219i Medicin\u0103, 157<\/em>(1), 77\u201380. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.1007\/s10517-014-2496-y\" target=\"_new\" rel=\"noopener\" data-start=\"1864\" data-end=\"1905\">https:\/\/doi.org\/10.1007\/s10517-014-2496-y<\/a><\/span><br data-start=\"1905\" data-end=\"1908\" \/><span style=\"font-size: 10pt;\">PubMed: <a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24909721\/\" target=\"_new\" rel=\"noopener\" data-start=\"1916\" data-end=\"1957\">https:\/\/pubmed.ncbi.nlm.nih.gov\/24909721\/<\/a><\/span><\/li>\n<li data-start=\"1959\" data-end=\"2332\"><span style=\"font-size: 10pt;\">Kraskovskaya, N. A., Kukanova, E. O., Lin\u2019kova, N. S., Popugaeva, E. A. \u0219i Khavinson, V. K. (2017). <em data-start=\"2063\" data-end=\"2171\">Tripeptidele restabilesc num\u0103rul de spini neuronali \u00een condi\u021bii de modelare in vitro a bolii Alzheimer<\/em>. <em data-start=\"2173\" data-end=\"2225\">Buletinul de Biologie Experimental\u0103 \u0219i Medicin\u0103, 163<\/em>(4), 547\u2013550. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.1007\/s10517-017-3847-2\" target=\"_new\" rel=\"noopener\" data-start=\"2239\" data-end=\"2280\">https:\/\/doi.org\/10.1007\/s10517-017-3847-2<\/a><\/span><br data-start=\"2280\" data-end=\"2283\" \/><span style=\"font-size: 10pt;\">PubMed: <a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28853087\/\" target=\"_new\" rel=\"noopener\" data-start=\"2291\" data-end=\"2332\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28853087\/<\/a><\/span><\/li>\n<li data-start=\"2334\" data-end=\"2684\"><span style=\"font-size: 10pt;\">Khavinson, V., Ilina, A., Kraskovskaya, N., Linkova, N., Kolchina, N., Mironova, E., Erofeev, A. \u0219i Petukhov, M. (2021). <em data-start=\"2459\" data-end=\"2561\">Efectele neuroprotectoare ale tripeptidelor \u2014 regulatori epigenetici \u00eentr-un model murin al bolii Alzheimer<\/em>. <em data-start=\"2563\" data-end=\"2584\">Produse farmaceutice, 14<\/em>(6), 515. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.3390\/ph14060515\" target=\"_new\" rel=\"noopener\" data-start=\"2594\" data-end=\"2628\">https:\/\/doi.org\/10.3390\/ph14060515<\/a><\/span><br data-start=\"2628\" data-end=\"2631\" \/><span style=\"font-size: 10pt;\">Link c\u0103tre jurnal: <a class=\"decorated-link\" href=\"https:\/\/www.mdpi.com\/1424-8247\/14\/6\/515\" target=\"_new\" rel=\"noopener\" data-start=\"2645\" data-end=\"2684\">https:\/\/www.mdpi.com\/1424-8247\/14\/6\/515<\/a><\/span><\/li>\n<li data-start=\"2686\" data-end=\"2998\"><span style=\"font-size: 10pt;\">Tsai, S. J. (2007). <em data-start=\"2710\" data-end=\"2862\">Semax, un analog al adrenocorticotropinei (4\u201310), este un poten\u021bial agent pentru tratamentul tulbur\u0103rii de hiperactivitate cu deficit de aten\u021bie \u0219i al sindromului Rett<\/em>. <em data-start=\"2864\" data-end=\"2888\">Medical Hypotheses, 68<\/em>(5), 1144\u20131146. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.1016\/j.mehy.2006.07.017\" target=\"_new\" rel=\"noopener\" data-start=\"2904\" data-end=\"2946\">https:\/\/doi.org\/10.1016\/j.mehy.2006.07.017<\/a><\/span><br data-start=\"2946\" data-end=\"2949\" \/><span style=\"font-size: 10pt;\">PubMed: <a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16996699\/\" target=\"_new\" rel=\"noopener\" data-start=\"2957\" data-end=\"2998\">https:\/\/pubmed.ncbi.nlm.nih.gov\/16996699\/<\/a><\/span><\/li>\n<li data-start=\"3000\" data-end=\"3502\"><span style=\"font-size: 10pt;\">Dolotov, O. V., Karpenko, E. A., Inozemtseva, L. S., Seredenina, T. S., Levitskaya, N. G., Rozyczka, J., Dubynina, E. V., Novosadova, E. V., Andreeva, L. A., Alfeeva, L. Y., Kamensky, A. A., Grivennikov, I. A., Myasoedov, N. F., &amp; Engele, J. (2006). <em data-start=\"3254\" data-end=\"3368\">Semax, un analog al ACTH(4\u201310) cu efecte cognitive, regleaz\u0103 expresia BDNF \u0219i a trkB \u00een hipocampul \u0219obolanului<\/em>. <em data-start=\"3370\" data-end=\"3392\">Brain Research, 1117<\/em>(1), 54\u201360. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.1016\/j.brainres.2006.07.108\" target=\"_new\" rel=\"noopener\" data-start=\"3404\" data-end=\"3450\">https:\/\/doi.org\/10.1016\/j.brainres.2006.07.108<\/a><\/span><br data-start=\"3450\" data-end=\"3453\" \/><span style=\"font-size: 10pt;\">PubMed: <a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16996037\/\" target=\"_new\" rel=\"noopener\" data-start=\"3461\" data-end=\"3502\">https:\/\/pubmed.ncbi.nlm.nih.gov\/16996037\/<\/a><\/span><\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"<p>&nbsp; Pinealon \u0219i alte peptide Odat\u0103 cu cre\u0219terea interesului pentru interven\u021biile bazate pe peptide, Pinealon este adesea comparat cu c\u00e2teva peptide bine cunoscute, printre care Epitalon, Semax,\u2026<\/p>","protected":false},"author":7908,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[253],"tags":[],"class_list":["post-51179","post","type-post","status-publish","format-standard","hentry","category-kategoria-pinealon","beh-no-thumb"],"_links":{"self":[{"href":"https:\/\/bioevidencehub.com\/ro\/wp-json\/wp\/v2\/posts\/51179","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioevidencehub.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioevidencehub.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/ro\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/ro\/wp-json\/wp\/v2\/comments?post=51179"}],"version-history":[{"count":0,"href":"https:\/\/bioevidencehub.com\/ro\/wp-json\/wp\/v2\/posts\/51179\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioevidencehub.com\/ro\/wp-json\/wp\/v2\/media?parent=51179"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioevidencehub.com\/ro\/wp-json\/wp\/v2\/categories?post=51179"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioevidencehub.com\/ro\/wp-json\/wp\/v2\/tags?post=51179"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}